C-Path Appoints Neuropharmacology Expert as New Vice President – Rare and Orphan Disease Programs Dr. Collin Hovinga will lead two public-private partnerships at C-Path — the Rare Disease Cures Accelerator Data and Analytics P
October 26, 2022-October 27, 2022 CDISC US Interchange, in Austin, Texas Dates: October 26-27, 2022 The 2022 CDISC US Interchange is an event consisting of workshops, training courses, and a two-day Main
October 21, 2022-October 22, 2022 International LMS Research Roundtable Dates: Friday, October 21 and Saturday, October 22 Chicago, Illinois, USA The NLMSF, SPAEN, and the LMS Community of patients
October 19, 2022-October 23, 2022 2022 IDWeek, Washington D.C Dates: October 19-23, 2022 Sessions run daily Oct. 19-23 with the closing plenary ending at 11 a.m. on Sunday, Oct. 23. IDWeek is
C-Path’s Ramona Walls Promoted to Executive Director of Data Science TUCSON, Ariz., October 20, 2022 — Critical Path Institute (C-Path) has named Ramona L. Walls, Ph.D., as Executive Director of Da
C-Path and Sturge-Weber Foundation Announce Data Sharing Agreement to Support Treatment Development for Sturge-Weber Syndrome TUCSON, Ariz., October 20, 2022 — Critical Path Institute (C-Path) and the Sturge-Weber Foundation today announced a joint colla
C-Path’s Transplant Therapeutics Consortium Receives EMA Draft Qualification Opinion for iBox Scoring System The draft EMA qualification opinion is available for public consultation until November 17, 2022 Secondary endpoint prognostic for
October 1, 2022 Perspectives on Drug Development in Early ADPKD The Critical Path Institute’s Polycystic Disease Outcomes Consortium, including key stakeholders (patients, medical experts
C-Path to Lead Pre-Consortium Aimed at Transforming, Accelerating Medical Product Development in Alpha-1 Antitrypsin Deficiency TUCSON, Ariz., Oct. 6, 2022 — Critical Path Institute (C-Path) today announced that it has recently launched a pre-consortium co